Back to Resources

Brochures

Your partner for timely, accurate and high-quality preclinical efficacy studies

Gene to GMP: First-in-human in 8 Months with Optimized Cost

Navigating Recombinant Protein Production– Leveraging Aragen’s Multifaceted Expression Systems

Modalities for Mechanistic Exploration in Agrochemical Solutions

Paclitaxel-induced Peripheral Neuropathic Pain Model Developed at Aragen

Comprehensive Services for Immersive Corrosion Testing of Metals and Alloys Across a Wide Spectrum of Test Subjects

Comprehensive In-Vitro Microbial Kill Rate Studies for screening antimicrobial agents

Exploring Molecular Interactions Through Surface Plasmon Resonance

Experimental λ-Carrageenan-induced inflammatory pain model for testing novel analgesics

Genetic and Alternative Toxicity Testing for Compound Screening, Derisking and Selection

Comprehensive Solutions for Animal Health Biologics

Aragen Cell Line Development Solutions for Biologics CHO CLD Platforms

Phosphonamidite

Oligonucleotides

Flow Chemistry

Specialized Services in Custom Peptide Synthesis (Solution Phase)

Comprehensive DoE capabilities for Synthesis, Process Development and Manufacturing of Novel Chemical Entities (NCE’s)

Nitrosamine Risk Assessment

Comprehensive GLP regulated Ecotoxicology Services

Comprehensive and Regulated “Developmental and Reproduction Toxicology (DART)” studies

Intox Safety Assessment

Preclinical Safety Evaluation and Clinical Bioanalysis Services for Vaccines

Nonclinical Safety Assessment of New Biological Entities (NBEs)

Process Safety, Dust Explosion Testing Capabilities

Aragen Overview

Your Partner for Chemocatalysis Solutions

Nonclinical Safety Assessment of New Chemical Entities (NCE)

Aragen protein science solutions: Industry leading upstream and downstream capabilities

Highly Potent Active Pharmaceutical Ingredients (HPAPIs)

Biocatalysis Solutions

Streptozotocin-induced Diabetic Peripheral Neuropathic Pain Model Developed at Aragen

Targeted Protein Degradation Solutions

Aragen’s Preclinical Oncology Capabilities

Preclinical Evaluation of new Antifibrotics in IPF Rodent Models

Pharmacokinetic (PK) solutions in large animals

Formulation Solutions

Discovery Biology Solutions

ADME – DMPK Solutions

Extractables and Leachables Solutions

In Vitro Pharmacology Solutions

In Vivo Pharmacology Solutions

Nitrosamine Impurity Detection and Quantification

TOXVIT – Aragen In Vitro Toxicology Solutions

ICP-MS

Protein Analytics Solutions

Peptide Chemistry Solutions

API and Intermediates

Integrated Drug Discovery Solutions

Discovery Chemistry Solutions

Developability and Analytics Solutions

Contract Manufacturing Solutions

Integrated Cell Line Development Solutions

Small Molecule Process R&D and Manufacturing Solutions

Amylin Liver NASH (AMLN)

×

Contact An Expert Today!